Last reviewed · How we verify

NCT05869422: PCLDIT

Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women

Completed NA Last updated 11 June 2025
What this trial tests

NA trial testing Iron in Iron Deficiency (Without Anemia) in 59 participants. Completed in 21 December 2024.

Timeline
6 May 2024
Primary endpoint
21 December 2024
21 December 2024

Quick facts

Lead sponsorDr. Krayenbühl GmbH
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment59
Start date6 May 2024
Primary completion21 December 2024
Estimated completion21 December 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Krayenbühl GmbH

Who can join

Adults 18 to 50, female only, with Iron Deficiency (Without Anemia). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to investigate the efficacy of a low dose iron supplement (6mg) compared to a placebo tablet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Iron

Trials testing the same drug.

Other recruiting trials for Iron Deficiency (Without Anemia)

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing